# Sunshine Biopharma Announces $6 Million Public Offering Pricing

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/28044
Published: 2026-10-08T12:22:58.000Z
Updated: 2026-10-08T12:22:58.000Z
Section: Business

> The offering includes 10.9 million common units, with expected gross proceeds of about $6 million.

Sunshine Biopharma (SBFM) announced pricing for a public offering expected to generate about $6 million in gross proceeds, giving the company a new source of funding.

The offering includes 10.9 million common units.

The announcement was made Oct. 8, 2026.